Once again the President has been shown to be right. A new study conducted by the Henry Ford Health System found that those COVID-19 patients given hydroxychloroquine (HCQ) in a hospital setting were far less likely to die. The study covered 2,541 hospitalized patients.
CNN reported the “surprising” results. Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said,
“What we think was important in ours … is that patients were treated early. For hydroxychloroquine to have a benefit, it needs to begin before the patients begin to suffer some of the severe immune reactions that patients can have with Covid.”
Continue reading...